Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 4Phase 1 2Phase NA 1Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Hematologic Neoplasms 31Lymphoma, Non-Hodgkin 24Leukemia 22Leukemia, Lymphocytic, Chronic, B-Cell 16Myelodysplastic Syndromes 15Multiple Myeloma 13Recurrence 10Lymphoma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, B-Cell 9Neoplasms 8Lymphoma, Mantle-Cell 7Burkitt Lymphoma 7Lymphoma, Follicular 6Leukemia, Plasma Cell 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia, B-Cell 6Hodgkin Disease 6Primary Myelofibrosis 5Lymphoma, T-Cell, Peripheral 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myeloid 5Hematologic Diseases 5Waldenstrom Macroglobulinemia 4Myeloproliferative Disorders 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Large Granular Lymphocytic 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Chromosome 17 deletion × Other hematologic neoplasm × Clear all
NCT03272633 2023-06-26

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Rutgers, The State University of New Jersey

Phase EARLY_PHASE1 Terminated
2 enrolled 6 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡